HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
BRONCUS-B (02216) spent HK$93,000 to repurchase 150,000 shares on January 21st.
21/01/2025
GMT Eight
BRONCUS-B (02216) announced on January 21, 2025 to repurchase 150,000 shares at a cost of HK$93,000.
INFINITY L&T(01442): Datin Paduka TPr. Noraini appointed as an independent non-executive director.
On January 21, AIA (01299) spent approximately HK$61.44 million to repurchase 1.1052 million shares.
RECOMMEND
The FDA has approved Johnson & Johnson's Spravato (esketamine) nasal spray for the treatment of adults with treatment-resistant depression (TRD).
15 min ago
GMTEight List of A-share restricted sales and lifting restrictions | January 22nd
22 min ago
Content is king! Netflix (NFLX.US) has once again won the "streaming game".
23 min ago
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com